Overview :: Arch Therapeutics, Inc. (ARTH)
Ir Arch Therapeutics. Company Profile...
Read Ir.archtherapeutics.com news digest here: view the latest Ir Arch Therapeutics articles and content updates right away or get to their most visited pages. Ir.archtherapeutics.com is not yet rated by Alexa and its traffic estimate is unavailable. It seems that Ir Arch Therapeutics content is notably popular in USA. We haven’t detected security issues or inappropriate content on Ir.archtherapeutics.com and thus you can safely use it. Ir.archtherapeutics.com is hosted with Amazon Technologies Inc. (United States) and its basic language is English.
Content verdict: Safe
Website availability: Live
Language: English
Last check:
-
N/A
Visitors daily -
N/A
Pageviews daily -
N/A
Google PR -
N/A
Alexa rank
Best pages on Ir.archtherapeutics.com
-
Press Releases :: Arch Therapeutics, Inc. (ARTH)
Framingham, MA 01702
-
FAQ :: Arch Therapeutics, Inc. (ARTH)
Our stock is traded on the OTCQB under the symbol ARTH. Can I buy stock directly from Arch Therapeutics, Inc.? No, you will need to contact a licensed stock broker or use an online trading account. Ho...
-
Overview :: Arch Therapeutics, Inc. (ARTH)
Company Profile Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and int...
Ir.archtherapeutics.com news digest
-
5 years
Arch Therapeutics Announces Submission of CE Mark File for AC5™ Topical Hemostat...
Company anticipates review process could take up to six months
FRAMINGHAM, Mass., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel liquid, gel and solid hemostatic and wound care devices, today announced that the Company has submitted the required... -
5 years
Arch Therapeutics to Provide Corporate Update at the 11th Annual LD Micro Main E...
Company to provide regulatory filing status update
FRAMINGHAM, Mass., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a presenting company at the LD Micro... -
6 years
Arch Therapeutics Announces 510(k) Submission to the U.S. FDA for AC5™ Topical G...
FRAMINGHAM, Mass., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel liquid, gel and solid hemostatic and wound care devices, today announced that the Company submitted a 510(k) notification...
-
6 years
Arch Therapeutics to Provide Corporate Update at the Ladenburg Thalmann 2018 Hea...
FRAMINGHAM, Mass., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a presenting company at the Ladenburg...
Domain history
| Web host: | Amazon Technologies Inc. |
| Registrar: | GoDaddy.com, LLC |
| Registrant: | Registration Private (Domains By Proxy, LLC) |
| Updated: | March 05, 2022 |
| Expires: | March 04, 2025 |
| Created: | March 04, 2008 |
Whois record
Safety scores
Trustworthiness
N/AChild safety
N/A
